RU2411249C2 - Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2 - Google Patents

Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2 Download PDF

Info

Publication number
RU2411249C2
RU2411249C2 RU2008148880/10A RU2008148880A RU2411249C2 RU 2411249 C2 RU2411249 C2 RU 2411249C2 RU 2008148880/10 A RU2008148880/10 A RU 2008148880/10A RU 2008148880 A RU2008148880 A RU 2008148880A RU 2411249 C2 RU2411249 C2 RU 2411249C2
Authority
RU
Russia
Prior art keywords
arg
gly
glu
type
tyr
Prior art date
Application number
RU2008148880/10A
Other languages
Russian (ru)
Other versions
RU2008148880A (en
Inventor
Людмила Александровна Андреева (RU)
Людмила Александровна Андреева
Марина Владимировна Мезенцева (RU)
Марина Владимировна Мезенцева
Ирина Михайловна Шаповал (RU)
Ирина Михайловна Шаповал
Вахтанг Эдуардович Щербенко (RU)
Вахтанг Эдуардович Щербенко
Феликс Иванович Ершов (RU)
Феликс Иванович Ершов
Николай Федорович Мясоедов (RU)
Николай Федорович Мясоедов
Original Assignee
Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН)
Государственное учреждение Научно-исследовательский институт эпидемиологии и микробиологии им. почетного академика Н.Ф. Гамалеи Российской академии медицинских наук (ГУ НИИЭМ им. Н.Ф. Гамалеи РАМН)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН), Государственное учреждение Научно-исследовательский институт эпидемиологии и микробиологии им. почетного академика Н.Ф. Гамалеи Российской академии медицинских наук (ГУ НИИЭМ им. Н.Ф. Гамалеи РАМН) filed Critical Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН)
Priority to RU2008148880/10A priority Critical patent/RU2411249C2/en
Publication of RU2008148880A publication Critical patent/RU2008148880A/en
Application granted granted Critical
Publication of RU2411249C2 publication Critical patent/RU2411249C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology. Offered is an agent for viruses; encephalomyocarditis, influenza type A, herpes simplex type 2, representing peptides of general formula A-B-C-D-Gly-Pro-X, where A - 0, Met, Ala, Lys, Gly, Glu, Arg, His, Phe, Thr; B - 0; Arg, Asp, Gly, Glu, Phe, Pro, Arg, Tyr, His, Lys; C - 0, Arg, Asp, Gly, Glu, Tyr, Yal, Phe; D- 0, Pro, His, Arg, Lys, Tyr, Thr, X - 0, Arg, Gly, Glu, Asp, Leu, where 0 is the absence of an amino acid residue.
EFFECT: invention extends the range of products for antiviral control.
13 tbl, 16 ex

Description

Текст описания приведен в факсимильном виде.

Figure 00000001
Figure 00000002
Figure 00000003
Figure 00000004
Figure 00000005
Figure 00000006
Figure 00000007
Figure 00000008
Figure 00000009
Figure 00000010
Figure 00000011
Figure 00000012
Figure 00000013
Figure 00000014
Figure 00000015
Figure 00000016
Figure 00000017
Figure 00000018
Figure 00000019
Figure 00000020
Figure 00000021
Figure 00000022
Figure 00000023
Figure 00000024
Figure 00000025
Figure 00000026
Figure 00000027
Figure 00000028
Figure 00000029
Figure 00000030
Figure 00000031
Figure 00000032
Figure 00000033
Figure 00000034
Figure 00000035
Figure 00000036
Figure 00000037
Figure 00000038
Figure 00000039
Figure 00000040
Figure 00000041
Figure 00000042
Figure 00000043
Figure 00000044
Figure 00000045
Figure 00000046
Figure 00000047
Figure 00000048
Figure 00000049
Figure 00000050
Figure 00000051
Figure 00000052
Figure 00000053
Figure 00000054
Figure 00000055
Figure 00000056
Figure 00000057
Figure 00000058
Figure 00000059
Figure 00000060
Figure 00000061
Figure 00000062
Figure 00000063
Figure 00000064
Figure 00000065
Figure 00000066
Figure 00000067
Figure 00000068
Figure 00000069
Figure 00000070
Figure 00000071
Figure 00000072
Figure 00000073
Figure 00000074
Figure 00000075
Figure 00000076
Figure 00000077
Figure 00000078
Figure 00000079
Figure 00000080
Figure 00000081
Figure 00000082
Figure 00000083
Figure 00000084
Figure 00000085
Figure 00000086
Figure 00000087
Figure 00000088
Figure 00000089
Figure 00000090
Figure 00000091
Figure 00000092
Figure 00000093
Figure 00000094
Figure 00000095
Figure 00000096
Figure 00000097
Figure 00000098
Figure 00000099
Figure 00000100
Figure 00000101
Figure 00000102
Figure 00000103
Figure 00000104
Figure 00000105
Figure 00000106
Figure 00000107
Figure 00000108
Figure 00000109
Figure 00000110
Figure 00000111
Figure 00000112
Figure 00000113
Figure 00000114
Figure 00000115
Figure 00000116
Figure 00000117
Figure 00000118
Figure 00000119
Figure 00000120
Figure 00000121
Figure 00000122
Figure 00000123
Figure 00000124
Figure 00000125
Figure 00000126
Figure 00000127
Figure 00000128
Figure 00000129
Figure 00000130
Figure 00000131
Figure 00000132
Figure 00000133
Figure 00000134
Figure 00000135
Figure 00000136
Figure 00000137
Figure 00000138
Figure 00000139
Figure 00000140
Figure 00000141
Figure 00000142
Figure 00000143
Figure 00000144
Figure 00000145
Figure 00000146
Figure 00000147
Figure 00000148
Figure 00000149
Figure 00000150
Figure 00000151
Figure 00000152
Figure 00000153
Figure 00000154
Figure 00000155
Figure 00000156
Figure 00000157
Figure 00000158
Figure 00000159
Figure 00000160
Figure 00000161
Figure 00000162
Figure 00000163
Figure 00000164
Figure 00000165
Figure 00000166
Figure 00000167
Figure 00000168
Figure 00000169
Figure 00000170
Figure 00000171
Figure 00000172
Figure 00000173
Figure 00000174
Figure 00000175
Figure 00000176
Figure 00000177
Figure 00000178
Figure 00000179
Figure 00000180
Figure 00000181
Figure 00000182
Figure 00000183
Figure 00000184
Figure 00000185
Figure 00000186
Figure 00000187
Figure 00000188
Figure 00000189
Figure 00000190
Figure 00000191
Figure 00000192
Figure 00000193
Figure 00000194
Figure 00000195
Figure 00000196
Figure 00000197
Figure 00000198
Figure 00000199
Figure 00000200
Figure 00000201
Figure 00000202
Figure 00000203
Figure 00000204
Figure 00000205
Figure 00000206
Figure 00000207
Figure 00000208
Figure 00000209
Figure 00000210
The text of the description is given in facsimile form.
Figure 00000001
Figure 00000002
Figure 00000003
Figure 00000004
Figure 00000005
Figure 00000006
Figure 00000007
Figure 00000008
Figure 00000009
Figure 00000010
Figure 00000011
Figure 00000012
Figure 00000013
Figure 00000014
Figure 00000015
Figure 00000016
Figure 00000017
Figure 00000018
Figure 00000019
Figure 00000020
Figure 00000021
Figure 00000022
Figure 00000023
Figure 00000024
Figure 00000025
Figure 00000026
Figure 00000027
Figure 00000028
Figure 00000029
Figure 00000030
Figure 00000031
Figure 00000032
Figure 00000033
Figure 00000034
Figure 00000035
Figure 00000036
Figure 00000037
Figure 00000038
Figure 00000039
Figure 00000040
Figure 00000041
Figure 00000042
Figure 00000043
Figure 00000044
Figure 00000045
Figure 00000046
Figure 00000047
Figure 00000048
Figure 00000049
Figure 00000050
Figure 00000051
Figure 00000052
Figure 00000053
Figure 00000054
Figure 00000055
Figure 00000056
Figure 00000057
Figure 00000058
Figure 00000059
Figure 00000060
Figure 00000061
Figure 00000062
Figure 00000063
Figure 00000064
Figure 00000065
Figure 00000066
Figure 00000067
Figure 00000068
Figure 00000069
Figure 00000070
Figure 00000071
Figure 00000072
Figure 00000073
Figure 00000074
Figure 00000075
Figure 00000076
Figure 00000077
Figure 00000078
Figure 00000079
Figure 00000080
Figure 00000081
Figure 00000082
Figure 00000083
Figure 00000084
Figure 00000085
Figure 00000086
Figure 00000087
Figure 00000088
Figure 00000089
Figure 00000090
Figure 00000091
Figure 00000092
Figure 00000093
Figure 00000094
Figure 00000095
Figure 00000096
Figure 00000097
Figure 00000098
Figure 00000099
Figure 00000100
Figure 00000101
Figure 00000102
Figure 00000103
Figure 00000104
Figure 00000105
Figure 00000106
Figure 00000107
Figure 00000108
Figure 00000109
Figure 00000110
Figure 00000111
Figure 00000112
Figure 00000113
Figure 00000114
Figure 00000115
Figure 00000116
Figure 00000117
Figure 00000118
Figure 00000119
Figure 00000120
Figure 00000121
Figure 00000122
Figure 00000123
Figure 00000124
Figure 00000125
Figure 00000126
Figure 00000127
Figure 00000128
Figure 00000129
Figure 00000130
Figure 00000131
Figure 00000132
Figure 00000133
Figure 00000134
Figure 00000135
Figure 00000136
Figure 00000137
Figure 00000138
Figure 00000139
Figure 00000140
Figure 00000141
Figure 00000142
Figure 00000143
Figure 00000144
Figure 00000145
Figure 00000146
Figure 00000147
Figure 00000148
Figure 00000149
Figure 00000150
Figure 00000151
Figure 00000152
Figure 00000153
Figure 00000154
Figure 00000155
Figure 00000156
Figure 00000157
Figure 00000158
Figure 00000159
Figure 00000160
Figure 00000161
Figure 00000162
Figure 00000163
Figure 00000164
Figure 00000165
Figure 00000166
Figure 00000167
Figure 00000168
Figure 00000169
Figure 00000170
Figure 00000171
Figure 00000172
Figure 00000173
Figure 00000174
Figure 00000175
Figure 00000176
Figure 00000177
Figure 00000178
Figure 00000179
Figure 00000180
Figure 00000181
Figure 00000182
Figure 00000183
Figure 00000184
Figure 00000185
Figure 00000186
Figure 00000187
Figure 00000188
Figure 00000189
Figure 00000190
Figure 00000191
Figure 00000192
Figure 00000193
Figure 00000194
Figure 00000195
Figure 00000196
Figure 00000197
Figure 00000198
Figure 00000199
Figure 00000200
Figure 00000201
Figure 00000202
Figure 00000203
Figure 00000204
Figure 00000205
Figure 00000206
Figure 00000207
Figure 00000208
Figure 00000209
Figure 00000210

Claims (1)

Средство против вирусов: энцефаломиокардита, гриппа А, простого герпеса 2, представляющее собой пептиды общей формулы
Figure 00000211
,
где А - 0, Met, Ala, Lys, Gly, Glu, Arg, His, Phe, Thr;
Б - 0, Ala, Asp, Gly, Glu, Phe, Pro, Arg, Tyr, His, Lys;
В - 0, Arg, Asp, Gly, Glu, Tyr, Val, Phe;
Г - 0, Pro, His, Arg, Lys, Tyr, Thr;
X - 0, Arg, Gly, Glu, Asp, Leu,
где 0 - отсутствие аминокислотного остатка. Anti-virus agent: encephalomyocarditis, influenza A, herpes simplex 2, which are peptides of the general formula
Figure 00000211
,
where A is 0, Met, Ala, Lys, Gly, Glu, Arg, His, Phe, Thr;
B - 0, Ala, Asp, Gly, Glu, Phe, Pro, Arg, Tyr, His, Lys;
B = 0, Arg, Asp, Gly, Glu, Tyr, Val, Phe;
G - 0, Pro, His, Arg, Lys, Tyr, Thr;
X - 0, Arg, Gly, Glu, Asp, Leu,
where 0 is the absence of an amino acid residue.
RU2008148880/10A 2008-12-11 2008-12-11 Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2 RU2411249C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008148880/10A RU2411249C2 (en) 2008-12-11 2008-12-11 Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008148880/10A RU2411249C2 (en) 2008-12-11 2008-12-11 Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2

Publications (2)

Publication Number Publication Date
RU2008148880A RU2008148880A (en) 2010-06-20
RU2411249C2 true RU2411249C2 (en) 2011-02-10

Family

ID=42682309

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008148880/10A RU2411249C2 (en) 2008-12-11 2008-12-11 Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2

Country Status (1)

Country Link
RU (1) RU2411249C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150111837A1 (en) * 2012-03-28 2015-04-23 "Ivix" Ltd. Method for Producing a Recombinant Peptide and Resultant Peptide
US10836794B2 (en) 2016-10-24 2020-11-17 “Ivix” Ltd. Group of peptides for treating female sexual dysfunction

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150111837A1 (en) * 2012-03-28 2015-04-23 "Ivix" Ltd. Method for Producing a Recombinant Peptide and Resultant Peptide
US9409947B2 (en) * 2012-03-28 2016-08-09 “Ivix” Ltd. Method for producing a recombinant peptide and resultant peptide
US10836794B2 (en) 2016-10-24 2020-11-17 “Ivix” Ltd. Group of peptides for treating female sexual dysfunction

Also Published As

Publication number Publication date
RU2008148880A (en) 2010-06-20

Similar Documents

Publication Publication Date Title
Vilas Boas et al. Antiviral peptides as promising therapeutic drugs
BRPI0816405B8 (en) RNA and cationic peptide complexes for transfection and immunostimulation
EP2708549A3 (en) Improved vaccines and methods for using the same
CY1113117T1 (en) HLA-A * 3303-LIMITED WT1 PIPE AND PHARMACEUTICAL COMPOSITION THAT INCLUDES HIS OWN
WO2010007622A3 (en) Long-acting interferons and derivatives thereof and methods thereof
EP2574619A3 (en) Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap
CL2012000119A1 (en) Recombinant respiratory syncytial virus polypeptide f, immunogenic composition comprising it, use for the preparation of a medicament for prophylaxis against said virus.
EP2383285A3 (en) Peptide Sequences and Compositions
WO2009026465A3 (en) Composition and methods of making and using influenza proteins
PL1879612T3 (en) Use of native peptides and their optimized derivatives for vaccination
WO2009097530A3 (en) Peptides that target dorsal root ganglion neurons
PE20090683A1 (en) SIGNALING PEPTIDES
RU2411249C2 (en) Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2
MX354302B (en) Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure.
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
WO2018224573A8 (en) Recombinant measles virus expressing zika virus proteins and their applications
FI3737399T3 (en) Atf5 peptide variants and uses thereof
CL2017000200A1 (en) Enhanced host cell to produce proteins
WO2020109780A3 (en) Polypeptide and uses thereof
EP2552490A4 (en) Ectodomains of influenza matrix 2 protein, expression system, and uses thereof
WO2007068240A3 (en) Peptides interacting with alpha-helical coiled-coil structures and/or coiled-coil sequences, substances derived therefrom, and use thereof
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
WO2012135600A3 (en) Gall wasp control agents
AR054259A1 (en) VACCINE AGAINST HUMAN PAPILOMA VIRUS (HPV)
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus

Legal Events

Date Code Title Description
TK4A Correction to the publication in the bulletin (patent)

Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 4-2011 FOR TAG: (73)

PD4A Correction of name of patent owner